Overview

Pharmacokinetics of HR17031 Injection in Healthy Subjects

Status:
Active, not recruiting
Trial end date:
2021-10-08
Target enrollment:
Participant gender:
Summary
To compare the pharmacokinetics and safety of HR17031 injection, SHR20004 injection and/or INS068 injection in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.